KRT5 and adenocarcinoma: When used in conjunction with cytokeratin 5/6 (CK5/6) and p63, this triad achieves a classification accuracy of 96.2% (94.6% for adenocarcinoma, 97.6% for SCC) (Galindo et al., 2020).